|
Jul 30
|
Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight
|
|
Jul 30
|
Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval
|
|
Jul 30
|
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
|
|
Jun 30
|
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025
|
|
Oct 8
|
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
|
|
Oct 7
|
AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline
|
|
Apr 26
|
Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023
|